Showing results (201-210 of 6,760) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|February 8, 2022
Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2Vincent Martin, A Jim Nagy, Marina Janelidze, et al.Clinical Therapeutics|June 4, 2019
Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database StudyChunping Wang, Yue Gao, Lifeng Zhu, et al.Clinical Therapeutics|June 2, 2019
Real-life Performance of Edoxaban in Elderly Patients With Atrial Fibrillation: a Multicenter Propensity Score-Matched Cohort StudyVincenzo Russo, Emilio Attena, Carmine Mazzone, et al.Clinical Therapeutics|January 1, 1987
Comparison of transdermal nitroglycerin therapy with previous long-acting oral or ointment nitrate therapyD A ChinoyClinical Therapeutics|June 6, 2019
Propafenone-associated Gross Hematuria: A Case Report and Review of the LiteratureShuqing Chen, Wenhui Ding, Jing Ye, et al.Clinical Therapeutics|June 15, 2019
Extra-articular Manifestations and Comorbidity in Rheumatoid Arthritis: Potential Impact of Pre-Rheumatoid Arthritis PreventionJon T GilesClinical Therapeutics|June 15, 2019
Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid ArthritisMarie Falahee, Axel Finckh, Karim Raza, et al.Clinical Therapeutics|June 15, 2019
Predicting Rheumatoid Arthritis in At-risk IndividualsLaurette van Boheemen, Dirkjan van SchaardenburgClinical Therapeutics|June 15, 2019
Potential Pharmacologic Targets for the Prevention of Rheumatoid ArthritisJohn D Isaacs, Kundan IqbalClinical Therapeutics|October 15, 2019
Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer in ChinaHaijing Guan, Gordon Liu, Feng Xie, et al.Pageof 676